Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
As of: Nov 16, 2026 · 3:54 PM EST

Elite Pharmaceuticals (ELTP) Long-Term Debt Repayments (2009 - 2026)

Updated

Analysis

Elite Pharmaceuticals (ELTP) Long-Term Debt Repayments (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 1.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn -4.91 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 3.05 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 19.00 Mn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 243,524.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 243,524.00
Jun 30, 2026 96,072.00
Mar 31, 2026 97,187.00
Dec 31, 2025 96,594.00
Sep 30, 2025 234,360.00
Jun 30, 2025 4.09 Mn
Mar 31, 2025 90,047.00
Dec 31, 2024 87,963.00
Sep 30, 2024 216,850.00
Jun 30, 2024 71,329.00
Mar 31, 2024 350,171.00
Mar 31, 2023 12.24 Mn
Mar 31, 2022 94,244.00
Dec 31, 2021 462,889.00
Mar 31, 2018 1.00
Mar 31, 2017 10,634.00
Dec 31, 2016 -10,634.00
Sep 30, 2015 119,062.00
Jun 30, 2015 90,938.00
Sep 30, 2009 -207,072.00
API Access

Elite Pharmaceuticals Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=ELTP&period=max&api_key=YOUR_API_KEY